Aptose Biosciences
APTO
#10464
Rank
โ‚น0.39 B
Marketcap
โ‚น154.00
Share price
0.00%
Change (1 day)
809.44%
Change (1 year)

Aptose Biosciences (APTO) - Net assets

Net assets on the balance sheet as of March 2025 : -โ‚น0.67 Billion

According to Aptose Biosciences's latest financial reports the company has -โ‚น0.67 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Aptose Biosciences - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2023-12-31$-โ‚น0.25 Billion-107.73%
2022-12-31$โ‚น3.12 B-43.48%
2021-12-31$โ‚น5.52 B-36.46%
2020-12-31$โ‚น8.69 B29.84%
2019-12-31$โ‚น6.69 B580.29%
2018-12-31$โ‚น0.98 B51.15%
2017-12-31$โ‚น0.65 B30.81%
2016-12-31$โ‚น0.49 B-45.11%
2015-12-31$โ‚น0.90 B
2014-05-31$โ‚น1.55 B-3738.19%
2013-05-31$-โ‚น42.73 Million-61.29%
2012-05-31$-โ‚น0.12 Billion-1103.29%
2011-05-31$โ‚น11 M-145.48%
2010-05-31$-โ‚น24.19 Million-93.27%
2009-05-31$-โ‚น0.36 Billion118.16%
2008-05-31$-โ‚น0.17 Billion-675.91%
2007-05-31$โ‚น28.59 M-126.72%
2006-05-31$-โ‚น0.11 Billion-123.16%
2005-05-31$โ‚น0.46 B-51.47%
2004-05-31$โ‚น0.95 B-3.82%
2003-05-31$โ‚น0.99 B-29.97%
2002-05-31$โ‚น1.41 B-17.19%
2001-05-31$โ‚น1.70 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Advaxis
ADXS
-โ‚น2.2 Billion 230.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
โ‚น9.99 B-1,601.30%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
โ‚น50.57 B-7,696.32%๐Ÿ‡บ๐Ÿ‡ธ USA